United States · FDA National Drug Code directory
LENALIDOMIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 47781-488_1c3e5289-7ff0-54c1-9146-f7ec3f49aea2
- Product NDC
- 47781-488
- Form
- CAPSULE
- Composition / generic term
- Lenalidomide
- Labeler
- Alvogen, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220903
- Source listing expiry
- 20261231
Source-listed ingredients
- LENALIDOMIDE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (47781-488-01) · 47781-488-01
- 21 CAPSULE in 1 BOTTLE (47781-488-77) · 47781-488-77
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →